Glaucoma is one of the leading causes of permanent blindness in the world, affecting more than two million Americans, and more than one hundred million people worldwide. It is a disease of the optic ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma can be a difficult management problem in a subset of patients, even for the most experienced glaucoma ...

CHICAGO -- Upfront laser trabeculoplasty significantly slowed glaucoma progression and vision loss as compared with eye drops, long-term follow-up from a large randomized trial showed. After 6 years ...

Oct 23 (Reuters) - This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive it in your inbox for free sign up here, opens new ...

Please provide your email address to receive an email when new articles are posted on . Frailty and older age are associated with significantly lower odds of undergoing surgery or laser treatment for ...

One hundred and forty million people suffer from glaucoma, a degenerative eye disease that can lead to blindness. It is most prevalent among people aged 60 and up. Glaucoma is generally preventable, ...

LOS ANGELES & MUNICH--(BUSINESS WIRE)--ELT Sight, Inc. today announced the company has acquired the IP and assets of MLase AG’s excimer ophthalmic laser system for glaucoma surgery. MLase manufactures ...

California-based medical technology startup ViaLase has announced that its ViaLase Laser device for glaucoma treatment has received CE mark approval. The approval moves the platform towards ...

LOS ANGELES & MUNICH--(BUSINESS WIRE)--ELT Sight, Inc. today announced that the American Medical Association (AMA) approved two new Category III Current Procedural Terminology (CPT®) codes to report ...